TEANECK, N.J., March 12, 2012
/PRNewswire/-- Herborium Group, Inc. (HBRM.PK),
www.herborium.com, is pleased to announce that the Phase
1 of due diligence for the sale of up to 100% interest to
China Health Resources Inc (OTCBB:CHRI) has been completed.
"We are very pleased with a timely progress of a due diligence and
the completion of the First Phase of the process that is the
exchange of the confidential information and documentation," stated
Dr. Agnes P. Olszewski CEO of Herborium Group.
"As we have stated in our Press Release of 02/24/2012 regarding a signed Letter of Intent
with China Health Resource Inc., both parties are highly
motivated to complete the process successfully and in a timely
fashion while guided by their fiduciary
responsibilities. Both parties are truly excited about
the opportunity and remain most optimistic of a smooth transaction
and final agreement," concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics®
company, focuses on developing, licensing, and marketing
proprietary, botanical based medicinal products to consumers and
healthcare professionals. The Company uses clinical
validation to establish and maintain a differential advantage. The
company sales its products in the US and Europe. For more information, please visit
www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends."
We cannot promise future returns. Our statements reflect our
best judgment at the time, and we disclaim any obligation to update
or alter forward-looking statements as the result of new
information or future events. The Company urges
investors to review the risks and uncertainties contained within
its filings with the OTC Markets and/or Securities and Exchange
Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.
